Taichung Tzu Chi Hospital
Taichung Tzu Chi Hospital
Shih J.-Y.,National University of Tainan |
Huang I.,National University of Tainan |
Chan S.-W.,Taichung Tzu Chi Hospital
Proceedings - 5th International Conference on Educational Innovation through Technology, EITT 2016 | Year: 2016
Breast cancer is one of Taiwan's female predilection cancers, screening for breast cancer through the mammography has been considered one of the most effective method, since breast cancer screening must have high professional, it is necessity and urgency to strengthen training. Diagnosis of breast cancer skills needed long-term clinical study and accumulated experience, most students often spend a lot of time and effort but still not get the hang of breast diagnostics. This research proposes the design of a learning system for training students in the interpretation of mammograms and diagnosis of breast cancer for beginners. This mammography e-learning system makes available image annotation editor that allow the students to draw the lesion of the breast, to discover breast cancer tissue. Moreover, the e-learning system is integrated with a test system that includes a feedback mechanism to allow students to be reviewed after completion of the test, all the resources are accessible via the web-browser. We expect that through this e-learning system allows medical students without time limit and place limit for learning, and looked forward to further combine others medical curriculum. © 2016 IEEE.
Chen J.-H.,Taichung Tzu Chi Hospital |
Chen J.-H.,Tzu Chi University |
Tsai C.-H.,China Medical University at Taichung |
Lin H.-Y.,China Medical University at Taichung |
And 8 more authors.
Molecular Neurobiology | Year: 2016
The expression of matrix metalloproteinase-13 (MMP-13) has been shown to be elevated in some pathophysiological conditions and is involved in the degradation of extracellular matrix in astrocytes. In current study, the function of MMP-13 was further investigated. The conditioned medium (CM) collected from activated microglia increased interleukin (IL)-18 production and enhanced MMP-13 expression in astrocytes. Furthermore, treatment with recombinant IL-18 increased MMP-13 protein and mRNA levels in astrocytes. Recombinant IL-18 stimulation also increased the enzymatic activity of MMP-13 and the migratory activity of astrocytes, while administration of MMP-13 or pan-MMP inhibitors antagonized IL-18-induced migratory activity of astrocytes. In addition, administration of recombinant IL-18 to astrocytes led to the phosphorylation of JNK, Akt, or PKCδ, and treatment of astrocytes with JNK, PI3 kinase/Akt, or PKCδ inhibitors significantly decreased the IL-18-induced migratory activity. Taken together, the results suggest that IL-18-induced MMP-13 expression in astrocytes is regulated by JNK, PI3 kinase/Akt, and PKCδ signaling pathways. These findings also indicate that IL-18 is an important regulator leading to MMP-13 expression and cell migration in astrocytes. © 2015, Springer Science+Business Media New York.
Chiu S.C.,Taichung Tzu Chi Hospital |
Huang S.Y.,Mackay Memorial Hospital |
Chen S.P.,Hualien Tzu Chi Hospital |
Su C.C.,Changhua Christian Hospital |
And 3 more authors.
Prostate Cancer and Prostatic Diseases | Year: 2013
BACKGROUND:Tanshinone IIA (Tan-IIA) is one of the major lipophilic components isolated from the root of Salviae Miltiorrhizae Radix. We explored the mechanisms of cell death induced by Tan-IIA treatment in prostate cancer cells in vitro and in vivo.METHODS:Cells were treated with Tan-IIA and growth inhibition was assessed. Cell cycle profiles after Tan-IIA treatment were determined by flow cytometry. Expression levels of cell cycle regulatory proteins and apoptosis-related proteins were determined after Tan-IIA treatment. Expression levels of endoplasmic reticulum (ER) stress-regulated genes were determined to investigate their role in Tan-IIA-induced cell death. GADD153 expression was knocked down by small interfering RNA (siRNA) transfection. Rate of cell death and proliferation was obtained by 3-(4,5-dimethyl thizol-2-yl)-2,5-diphenyl tetrazolium bromide assay. Antitumor activity of Tan-IIA was performed in LNCaP xenograft model.RESULTS:Our results showed that Tan-IIA caused prostate cancer cell death in a dose-dependent manner, and cell cycle arrest at G0/G1 phase was noted, in LNCaP cells. The G0/G1 phase arrest correlated with increase levels of CDK inhibitors (p16, p21 and p27) and decrease of the checkpoint proteins. Tan-IIA also induced ER stress in prostate cancer cells: activation and nuclear translocation of GADD153/CCAAT/enhancer- binding protein-homologous protein (CHOP) were identified, and increased expression of the downstream molecules GRP78/BiP, inositol-requiring protein-1 and GADD153/CHOP were evidenced. Blockage of GADD153/CHOP expression by siRNA reduced Tan-IIA-induced cell death in LNCaP cells. Tan-IIA also suppressed LNCaP xenograft tumor growth, causing 86.4% reduction in tumor volume after 13 days of treatment.CONCLUSIONS:Our findings suggest that Tan-IIA causes G0/G1 cell cycle arrest in LNCaP cells and its cytotoxicity is mediated at least partly by ER stress induction. These data provide evidence supporting Tan-IIA as a potential anticancer agent by inducing ER stress in prostate cancer. © 2013 Macmillan Publishers Limited All rights reserved.
Hsu M.-Y.,National Tsing Hua University |
Hsu M.-Y.,Taichung Veterans General Hospital |
Chen S.-J.,Taipei Veterans General Hospital |
Chen K.-H.,National Tsing Hua University |
And 3 more authors.
Lab on a Chip - Miniaturisation for Chemistry and Biology | Year: 2015
The purpose of this article is to demonstrate the capacity of paper-based ELISA (P-ELISA) to monitor VEGF in patients requiring treatment for vision-threatening diseases. The most commonly encountered vision-threatening diseases are age-related macular degeneration (AMD) and diabetic retinopathy (DR), both of which may require short-term or life-long anti-VEGF injection treatment therapy. Accurate measurement of VEGF concentration in aqueous humor can provide significant and timely information to diagnose the disease state. Adequate and precise therapy may consequently be provided. At odds with conventional diagnostic approaches is the fact that a maximum of only 200 microliters of aqueous humor can be safely removed from the eye for testing. Fortunately, new diagnostic platforms, such as P-ELISA, require only minute volumes, i.e., approximately 2 microliters per test "well" and approximately 40 microliters total to quantify VEGF levels, and the testing process takes less than an hour. Thus, point-of-care (POC) diagnostics, such as P-ELISA, should be examined and improved upon as needed in order to develop an efficient tool for outpatient clinics and others to obtain semi-quantitative results that might facilitate accurate dosing of anti-VEGF treatment and delay or prevent the progression of AMD and DR. This journal is © The Royal Society of Chemistry 2015.
Tsai C.-F.,Asia University, Taiwan |
Yeh W.-L.,Changhua Christian Hospital |
Chen J.-H.,Taichung Tzu Chi Hospital |
Lin C.,China Medical University at Taichung |
And 2 more authors.
International Journal of Molecular Sciences | Year: 2014
Glioblastoma multiforme (GBM) is the most common type of primary and malignant tumor occurring in the adult central nervous system. GBM often invades surrounding regions of the brain during its early stages, making successful treatment difficult. Osthole, an active constituent isolated from the dried C. monnieri fruit, has been shown to suppress tumor migration and invasion. However, the effects of osthole in human GBM are largely unknown. Focal adhesion kinase (FAK) is important for the metastasis of cancer cells. Results from this study show that osthole can not only induce cell death but also inhibit phosphorylation of FAK in human GBM cells. Results from this study show that incubating GBM cells with osthole reduces matrix metalloproteinase (MMP)-13 expression and cell motility, as assessed by cell transwell and wound healing assays. This study also provides evidence supporting the potential of osthole in reducing FAK activation, MMP-13 expression, and cell motility in human GBM cells. © 2014 by the authors; licensee MDPI, Basel, Switzerland.
Yang Y.-W.,China Medical University at Taichung |
Hsieh T.-F.,Taichung Tzu Chi Hospital |
Hsieh T.-F.,Tzu Chi University |
Yu C.-H.,Dalin Tzu Chi Hospital |
And 4 more authors.
Journal of Psychiatric Research | Year: 2014
Background: This nationwide population-based study investigated the risk of Parkinson's disease (PD) after zolpidem use in patients with sleep disturbance using the National Health Insurance Research Database (NHIRD) in Taiwan. Material and methods: In total, 59,548 adult patients newly diagnosed with sleep disturbance and who used zolpidem were recruited as the study cohort, along with 42,171 subjects who did not use zolpidem as a comparison cohort from 2002 to 2009. Each patient was monitored for 5 years, and those who subsequently had PD were identified. A Cox proportional hazards model was used to compare the risk of PD between the study and comparison cohorts after adjusting for possible confounding risk factors. Results: The patients who received zolpidem had a higher cumulative rate of PD than those who did not receive zolpidem during the 5-year follow-up period (1.2% vs. 0.5%, P<0.001). The adjusted hazard ratios were 1.10 (95% CI, 0.88-1.37), 1.41 (95% CI, 1.17-1.72), and 1.27 (95% CI, 1.05-1.55) for zolpidem use with 28-90, 91-365, and more than 365 cumulative defined daily doses (cDDDs), respectively, compared to those who did not use zolpidem. Conclusions: Among the patients with sleep disturbance, zolpidem use increased the risk of PD after 5 years of follow-up. Further mechanistic research of zolpidem effect in PD is needed. © 2014 Elsevier Ltd.
Hsu M.-Y.,Taichung General Veteran Hospital |
Hsu M.-Y.,National Tsing Hua University |
Yang C.-Y.,National Tsing Hua University |
Hsu W.-H.,National Chung Hsing University |
And 8 more authors.
Biomaterials | Year: 2014
The vascular endothelial growth factor (VEGF) level in aqueous humor has been used as an indicator to monitor specific diseases in the retinal ischemic condition. For clinical diagnosis, only about 200μL of aqueous humor can be collected from the anterior chamber before the threat of anterior chamber collapse. It is necessary to develop an inexpensive diagnostic approach with the characteristics of highly sensitive, short operation duration, and requires small clinical sample quantities. To achieve the main objective of this study, we first prepared bevacizumab to be conjugated with HRP. We then deposited 2μL aqueous humor from patients with different diseases onto each test zone of paper-based 96-well plates. After the colorimetric results were performed via ELISA protocol, the output signals were recorded using a commercial desktop scanner for analysis. In this study, only 2μL from the aqueous humor of each patient was required for paper-based ELISA. The mean aqueous VEGF level was 14.4pg/mL from thirteen patients (N=13) with senile cataract as the control. However, the mean aqueous VEGF level from other patients with proliferative diabetic retinopathy (N=14), age-related macular degeneration (N=17), and retinal vein occlusion (N=10) showed VEGF increases to 740.1pg/mL, 383pg/mL, and 219.4pg/mL, respectively. © 2014 Elsevier Ltd.
Huang S.-M.,National Chung Hsing University |
Huang S.-M.,Foundation Medicine |
Huang S.-M.,Taichung Tzu Chi Hospital |
Huang S.-M.,Tzu Chi University |
And 11 more authors.
Endocrine-Related Cancer | Year: 2014
Glial cell line-derived neurotrophic factor (GDNF), a potent neurotrophic factor, has been shown to affect cancer cell metastasis and invasion. However, the molecular mechanisms underlying GDNF-induced colon cancer cell migration remain unclear. GDNF is found to be positively correlated withmalignancy in human colon cancer patients. Themigratory activities of two human colon cancer cell lines, HCT116 and SW480, were found to be enhanced in the presence of humanGDNF. The expression of vascular endothelial growth factor (VEGF)was also increased in response to GDNF stimulation, along with VEGF mRNA expression and transcriptional activity. The enhancement of GDNF-induced cancer cell migration was antagonized by a VEGF-neutralizing antibody. Our results also showed that the expression of VEGF receptor 1 (VEGFR1) was increased in response to GDNF stimulation, whereas GDNF-inducedcancer cell migrationwas reducedby aVEGFRinhibitor. TheGDNF-inducedVEGF expression was regulated by the p38 and PI3K/Akt signaling pathways. Treatment with GDNF increased nuclear hypoxia-inducible factor 1 α (HIF1α) accumulation and its transcriptional activity in a time-dependent manner. Moreover, GDNF increased hypoxia responsive element (HRE)-containing VEGF promoter transcriptional activity but not that of the HRE-deletion VEGF promoter construct. Inhibition of HIF1α by a pharmacological inhibitor or dominant-negative mutant reduced theGDNF-inducedmigratory activity in human colon cancer cells. These results indicate that GDNF enhances the migration of colon cancer cells by increasing VEGF-VEGFR interaction, which is mainly regulated by the p38, PI3K/Akt, and HIF1α signaling pathways. © 2014 Society for Endocrinology.
Liao W.-L.,Foundation Medicine |
Liao W.-L.,China Medical University at Taichung |
Chang T.-P.,Taichung Tzu Chi Hospital |
Chen H.-J.,Data Management |
And 2 more authors.
Journal of Orthopaedic and Sports Physical Therapy | Year: 2015
STUDY DESIGN: A nationwide, population-based, retrospective cohort study. OBJECTIVES: To investigate whether benign paroxysmal positional vertigo (BPPV) is associated with an increased risk of fracture. BACKGROUND: Benign paroxysmal positional vertigo is a brief rotational vertigo induced by head position change that may increase the risk of falls and, therefore, fracture. METHODS: Data from the Taiwan National Health Insurance Research Database were used for this study. We selected a case cohort comprising 3796 patients aged over 20 years who were newly diagnosed with BPPV between 2000 and 2006. In addition, we randomly selected a control cohort of 15 184 individuals without BPPV. Patients with BPPV were matched to individuals in the control group according to sex, age, and index year. A Cox proportional hazard regression was performed to compute the hazard ratio of fracture, after adjusting for demographic characteristics and comorbidities. RESULTS: The prevalence of comorbidities was higher among patients with BPPV. After adjusting for age, sex, and comorbidities, patients with BPPV exhibited a 1.14-fold (95% confidence interval [CI]: 1.04, 1.25; P<.01) higher risk of fracture than those without BPPV. Trunk fracture (vertebra, rib, and pelvis) was the fracture type with the highest adjusted hazard ratio (1.24; 95% CI: 1.06, 1.45; P<.01) in patients with BPPV relative to those without BPPV. An analysis stratified according to demographic factors revealed that men with BPPV exhibited a 1.43-fold (95% CI: 1.22, 1.66; P<.001) higher risk of fracture. Patients with BPPV aged over 65 years exhibited a significantly higher risk of fracture (adjusted hazard ratio = 1.17; 95% CI: 1.03, 1.33; P<.05) than did those without BPPV. CONCLUSION: Patients with BPPV exhibited a higher risk of fracture than did those without BPPV. Copyright ©2015 Journal of Orthopaedic & Sports Physical Therapy® All rights reserved.
Wu M.-S.,Taichung Tzu Chi Hospital |
Su S.-F.,Hungkuang University
Journal of Nursing | Year: 2016
Aging frequently induces degenerative changes in the spine. Patients who suffer from lumbar degenerative disease tend to have lower back pain, neurological claudication, and neuropathy. Furthermore, incontinence may be an increasing issue as symptoms become severe. Lumbar spine fusion surgery is necessary if clinical symptoms continue to worsen or if the patient fails to respond to medication, physical therapy, or alternative treatments. However, this surgical procedure frequently induces adjacent segment disease (ASD), which is evidenced by the appearance of pathological changes in the upper and lower sections of the spinal surgical sites. In 1997, ISOBAR TTL dynamic rod stabilization was developed for application in spinal fusion surgery to prevent ASD-related complications. The device has proven effective in reducing pain in the lower back and legs, decreasing functional disability, improving quality of life, and retarding disc degeneration. However, the effectiveness of this intervention in decreasing the incidence of ASD requires further research investigation, and relevant literature and research in Taiwan is still lacking. This article discusses lumbar degenerative disease, its indications, the contraindications of lumbar spine fusion surgery using ISOBAR, and related postoperative nursing care. We hope this article provides proper and new knowledge to clinical nurses for the care of patients undergoing lumbar spine fusion surgery with ISOBAR.